Featured Research

from universities, journals, and other organizations

Myc's Cancer-Causing Joy Ride More Reckless Than Previously Believed

Date:
October 12, 1999
Source:
University Of Rochester
Summary:
Many drivers feel the urge to floor the accelerator on a crisp sunny day when the highway ahead seems to stretch straight to eternity. But only the most foolish would cut the brake line while pushing the pedal to the metal. Yet one of the body's most potent cancer-causing genes does precisely that inside a cell, scientists at the University of Rochester Medical Center have found.

Many drivers feel the urge to floor the accelerator on a crisp sunny day when the highway ahead seems to stretch straight to eternity. But only the most foolish would cut the brake line while pushing the pedal to the metal.

Yet one of the body's most potent cancer-causing genes does precisely that inside a cell, scientists at the University of Rochester Medical Center have found. The result of the unfettered molecular joy ride is, oftentimes, cancer. Details of the research are in the October issue of the Journal of the European Molecular Biology Organization (EMBO).

Scientists have long recognized that the protein produced by a gene known as myc spurs a cell to grow. Just like pushing the accelerator makes a car move forward, producing more myc makes a cell grow and divide. Too much myc spells an invitation to cancer, where cells grow uncontrollably and invade other tissues.

Now scientists have found that myc is even more powerful than they anticipated: The gene also has a role in disabling the molecular signals, the "brakes," that cells rely on to slow growth. When myc is out of control, not only is the accelerator floored but the brakes are out. It's no wonder that the gene plays a role in many human cancers, including those in the lung, colon, breast, bladder, and brain.

"Myc is central to our cells' ability to grow, divide, and even die when they should," says Hartmut Land, Ph.D., director of the University's Center for Cancer Biology and lead investigator of the EMBO study. "Basically, myc is like the starter of an engine; it's responsible for making the whole cell go. It's a very potent gene, but one that's been slow to yield its secrets. Myc has been a conundrum."

Land's team showed that myc controls another protein, cyclin D, known to play a big role in making cells grow; the EMBO paper marks the first time scientists have identified the "brains" behind cyclin D's actions. Land's team also found that cyclin D can not only accelerate growth, which has been known, but also knock out the proteins that a cell normally uses to put the brakes on growth, a surprising finding.

While Land says it's too early to know the implications of the work for cancer treatment, the findings mark another step in scientists' journey to unravel the amazing cell-signaling network that underlies our body's ability to produce cancer cells. That process is the focus of more than 100 scientists just joining the Center for Cancer Biology, a new effort begun by the University this year to study how faulty cell signals can conspire to cause cancer.

"Unraveling cell signaling is more or less like looking at a chess board and trying to figure out how the game is being played. What are the important rules? Who are the key players?" asks Land, who is the Robert and Dorothy Markin Professor of Cancer Biology.

"We're scratching the surface of a complexity that five years ago, nobody even dreamed about. The full texture of the biochemical circuitry of cells is just beginning to emerge, and that's exciting. Information like this helps us to understand how to manipulate cancer cells and ultimately should help us treat cancer in new and unexpected ways."

Land was one of the first to realize the immensity of the signaling network inside a cell, discovering in the early 1980s that multiple genetic changes are necessary for a cell to become cancerous. Much of his work has been done at the Imperial Cancer Research Fund in London, where Land did research before coming to the University this year.

Also contributing to the project research were Soo-Hyun Kim and Beatrice Griffiths of the Imperial Cancer Research Fund; Ignacio Perez-Roger, now at the Instituto de Biomedicina in Valencia, Spain; and Andreas Sewing, now with Smithkline Beecham Pharmaceuticals. The work was funded by the Imperial Cancer Research Fund and the European Community.


Story Source:

The above story is based on materials provided by University Of Rochester. Note: Materials may be edited for content and length.


Cite This Page:

University Of Rochester. "Myc's Cancer-Causing Joy Ride More Reckless Than Previously Believed." ScienceDaily. ScienceDaily, 12 October 1999. <www.sciencedaily.com/releases/1999/10/991012075440.htm>.
University Of Rochester. (1999, October 12). Myc's Cancer-Causing Joy Ride More Reckless Than Previously Believed. ScienceDaily. Retrieved August 21, 2014 from www.sciencedaily.com/releases/1999/10/991012075440.htm
University Of Rochester. "Myc's Cancer-Causing Joy Ride More Reckless Than Previously Believed." ScienceDaily. www.sciencedaily.com/releases/1999/10/991012075440.htm (accessed August 21, 2014).

Share This




More Health & Medicine News

Thursday, August 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
Ramen Health Risks: The Dark Side of the Noodle

Ramen Health Risks: The Dark Side of the Noodle

AP (Aug. 21, 2014) South Koreans eat more instant ramen noodles per capita than anywhere else in the world. But American researchers say eating too much may increase the risk of diabetes, heart disease and stroke. (Aug. 21) Video provided by AP
Powered by NewsLook.com
Possible Ebola Patient in Isolation at California Hospital

Possible Ebola Patient in Isolation at California Hospital

Reuters - US Online Video (Aug. 20, 2014) A patient who may have been exposed to the Ebola virus is in isolation at the Kaiser Permanente South Sacramento Medical Center. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins